@ARTICLE{
author={Chia Stephen KL|,...|,Tomasevic Zorica I|0000-0003-0171-6855,...|,(broj koautora 26)|},
year={2019},
title={PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial},
journal={BREAST CANCER RESEARCH},
volume={21},
number={},
pages={-},
document_type={Article},
} 

@ARTICLE{
author={Chia Stephen KL|,...|,Holmes Frankie Ann|,Ejlertsen Bent|,Delaloge Suzette|,Moy Beverly|,Iwata Hiroji|,von Minckwitz Gunter|,Mansi Janine|,Barrios Carlos H|,Gnant Michael|,Evic Zorica Toma|,Denduluri Neelima|,Eparovic Robert|,Kim Sung-Bae|,Jakobsen Erik Hugger|,Harvey Vernon|,Robert Nicholas|,Smith John II|,Harker Graydon|,Lalani Alshad S|,Zhang Bo|,Eli Lisa D|,Buyse Marc|,(broj koautora 25)|},
year={2018},
title={PIK3CA alterations and benefit with neratinib after trastuzumab-based adjuvant therapy in early-stage HER2+breast cancer: Correlative analyses of the phase III ExteNET trial},
journal={CANCER RESEARCH},
volume={78},
number={4},
pages={-},
document_type={Meeting Abstract},
}